Thermo Fisher Scientific (36)

Browse by Contract Category

Contracts

Twenty-Second Supplemental Indenture, dated as of August 23, 2021, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on August 23, 2021)
Agreement and Plan of Merger, dated as of April 15, 2021, by and among Thermo Fisher Scientific Inc., Powder Acquisition Corp. and PPD, Inc (Filed With SEC on April 16, 2021)
Form of Thermo Fisher Scientific Inc.s Performance Restricted Stock Unit Agreement (Filed With SEC on February 25, 2021)
Amendment No. 1 to the Business Combination Agreement, dated as of July 16, 2020, by and between Thermo Fisher Scientific, Inc. and QIAGEN N.V (Filed With SEC on July 16, 2020)
Underwriting Agreement, dated August 9, 2021, among the Company, as issuer, and Barclays Capital Inc., Morgan Stanley & Co. LLC, BofA Securities, Inc. and Citigroup Global Markets... (Filed With SEC on August 23, 2021)
Form of Performance Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc. and Marc Casper (Filed With SEC on February 25, 2021)
Form of Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc. and Marc Casper (Filed With SEC on February 25, 2021)
Thermo Fisher Scientific Inc. Amended and Restated 2005 Deferred Compensation Plan, effective January 1, 2020 (Filed With SEC on July 31, 2020)
Term Loan Credit Agreement, dated as of June 5, 2020, among Thermo Fisher Scientific Inc., each lender from time to time party thereto, and JPMorgan Chase Bank, N.A (Filed With SEC on June 11, 2020)
First Amendment to Bridge Credit Agreement, dated as of June 5, 2020, among Thermo Fisher Scientific Inc., the lenders party thereto, and JPMorgan Chase Bank, N.A (Filed With SEC on June 11, 2020)
Bridge Credit Agreement, dated as of April 17, 2020, among Thermo Fisher, each lender from time to time party thereto, and JPMorgan Chase Bank, N.A (Filed With SEC on April 23, 2020)
Twenty-First Supplemental Indenture, dated as of April 2, 2020, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on April 2, 2020)
Underwriting Agreement, dated March 30, 2020, among the Company, as issuer, and J.P. Morgan Securities plc, Morgan Stanley & Co. International plc, Merrill Lynch International and... (Filed With SEC on April 2, 2020)
Twentieth Supplemental Indenture, dated as of March 25, 2020, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on March 26, 2020)
Underwriting Agreement, dated March 23, 2020, among the Company, as issuer, and J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, BofA Securities, Inc., Deutsche Bank... (Filed With SEC on March 26, 2020)
Business Combination Agreement, dated as of March 3, 2020, between Thermo Fisher Scientific, Inc. and QIAGEN N.V (Filed With SEC on March 9, 2020)
Form of Stock Option Agreement between Thermo Fisher Scientific Inc. and Marc Casper (Filed With SEC on February 26, 2020)
Form of Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc. and Marc Casper (Filed With SEC on February 26, 2020)
Summary of Thermo Fisher Scientific Inc. Annual Director Compensation (Filed With SEC on February 26, 2020)
Form of Thermo Fisher Scientific Inc.s Stock Option Agreement for Officers (Filed With SEC on February 26, 2020)
Form of Thermo Fisher Scientific Inc.s Restricted Stock Unit Agreement (Filed With SEC on February 26, 2020)
Form of Thermo Fisher Scientific Inc.s Performance Restricted Stock Unit Agreement (Filed With SEC on February 26, 2020)
Option Agreement Under the Patheon N.V. 2016 Omnibus Incentive Plan between Patheon N.V. and Michel Lagarde dated March 23, 2017 (Filed With SEC on February 26, 2020)
Restricted Share Unit Award Agreement between Patheon N.V. and Michel Lagarde dated March 23, 201 (Filed With SEC on February 26, 2020)
Option Agreement Under the Patheon N.V. 2016 Omnibus Incentive Plan between Patheon N.V. and Michel Lagarde dated July 20, 2016 (Filed With SEC on February 26, 2020)
Letter Agreement between the Registrant and Michel Lagarde dated August 28, 2017 (Filed With SEC on February 26, 2020)
Form of Performance Restricted Stock Unit Agreement between Thermo Fisher Scientific Inc. and Marc Casper (Filed With SEC on February 26, 2020)
Description of the Registrants Securities (Filed With SEC on February 26, 2020)
Nineteenth Supplemental Indenture, dated as of October 8, 2019, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on October 8, 2019)
Eighteenth Supplemental Indenture, dated as of September 30, 2019, between the Company, as issuer, and The Bank of New York Mellon Trust Company, N.A., as trustee (Filed With SEC on September 30, 2019)
Underwriting Agreement, dated September 24, 2019, among the Company, as issuer, and BofA Securities, Inc., Goldman Sachs & Co. LLC, Credit Suisse Securities (USA) LLC and HSBC... (Filed With SEC on September 25, 2019)
Underwriting Agreement, dated September 24, 2019, among the Company, as issuer, and Merrill Lynch International, Goldman Sachs & Co. LLC, Citigroup Global Markets Limited and J.P.... (Filed With SEC on September 25, 2019)
Thermo Fisher Scientific Inc. Executive Severance Policy (Filed With SEC on August 2, 2019)
Form of Noncompetition Agreement between the Registrant and certain key employees and executive officers (Filed With SEC on August 2, 2019)
Form of Performance Restricted Stock Unit Agreement for Marc Casper effective February 26, 2019 (Filed With SEC on May 3, 2019)
Form of Performance Restricted Stock Unit Agreement effective February 26, 2019 (Filed With SEC on May 3, 2019)